Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moo Hyun Kim

Showing results (11-20 of 255) with videos related to

Pageof 26
Sort By:
The American Journal of Cardiology|November 12, 2003
Prevalence and clinical predictors of severe tortuosity of right subclavian artery in patients undergoing transradial coronary angiographyKwang Soo Cha, Moo Hyun Kim, Hje Jin Kim
ASEAN Heart Journal : Official Journal of the ASEAN Federation of Cardiology|August 29, 2015
Opposition: Unfractionated heparin should no longer be used in the catheterization laboratoryMoo Hyun Kim, Young Seok Lee, Michael S Lee
Circulation Journal : Official Journal of the Japanese Circulation Society|February 1, 2013
Pharmacodynamic comparisons for single loading doses of prasugrel (30 mg) and clopidogrel (600 mg) in healthy Korean volunteersMoo Hyun Kim, Hong-Zhe Zhang, Dong Keun Jung
Platelets|August 27, 2013
Predictive values of post-clopidogrel platelet reactivity assessed by different platelet function tests on ischemic events in East Asian patients treated with PCIHong-Zhe Zhang, Moo Hyun Kim, Young-Hoon Jeong
Coronary Artery Disease|January 19, 2024
Comparison of clinical outcomes in patients with mixed angina and pure vasospastic anginaZhao Yan Song, Moo Hyun Kim, Kwang Min Lee
Open Heart|August 2, 2017
Mortality and oral anticoagulants in the Food and Drug Administration Adverse Event Reporting SystemVictor Serebruany, Vasily Cherepanov, Seth Fortmann, et al.
International Journal of Cardiology|December 29, 2015
The FDA review on data quality and conduct in vorapaxar trials: Much better than in PLATO, but still not perfectVictor L Serebruany, Sun Young Choi, Moo Hyun Kim
International Journal of Cardiology|November 27, 2015
Vorapaxar and optimal aspirin dose: The FDA outlookVictor L Serebruany, Seth D Fortmann, Moo Hyun Kim
The Journal of Invasive Cardiology|June 18, 2016
Alternative Rota-Flush Solution for Patients With Severe Coronary Artery Calcification who Undergo Rotational AtherectomyMichael S Lee, Moo-Hyun Kim, Seung-Woon Rha
Acta Cardiologica|September 9, 2017
Rosuvastatin inhibits high glucose-stimulated upregulation of VCAM-1 via the MAPK-signalling pathway in endothelial cellsMoo Hyun Kim, Chae-Eun Kim, Sung-Whan Kim
Pageof 26

Showing results (11-20 of 255) with videos related to

Sort By:
Pageof 26
The American Journal of Cardiology|November 12, 2003
Prevalence and clinical predictors of severe tortuosity of right subclavian artery in patients undergoing transradial coronary angiographyKwang Soo Cha, Moo Hyun Kim, Hje Jin Kim
ASEAN Heart Journal : Official Journal of the ASEAN Federation of Cardiology|August 29, 2015
Opposition: Unfractionated heparin should no longer be used in the catheterization laboratoryMoo Hyun Kim, Young Seok Lee, Michael S Lee
Circulation Journal : Official Journal of the Japanese Circulation Society|February 1, 2013
Pharmacodynamic comparisons for single loading doses of prasugrel (30 mg) and clopidogrel (600 mg) in healthy Korean volunteersMoo Hyun Kim, Hong-Zhe Zhang, Dong Keun Jung
Platelets|August 27, 2013
Predictive values of post-clopidogrel platelet reactivity assessed by different platelet function tests on ischemic events in East Asian patients treated with PCIHong-Zhe Zhang, Moo Hyun Kim, Young-Hoon Jeong
Coronary Artery Disease|January 19, 2024
Comparison of clinical outcomes in patients with mixed angina and pure vasospastic anginaZhao Yan Song, Moo Hyun Kim, Kwang Min Lee
Open Heart|August 2, 2017
Mortality and oral anticoagulants in the Food and Drug Administration Adverse Event Reporting SystemVictor Serebruany, Vasily Cherepanov, Seth Fortmann, et al.
International Journal of Cardiology|December 29, 2015
The FDA review on data quality and conduct in vorapaxar trials: Much better than in PLATO, but still not perfectVictor L Serebruany, Sun Young Choi, Moo Hyun Kim
International Journal of Cardiology|November 27, 2015
Vorapaxar and optimal aspirin dose: The FDA outlookVictor L Serebruany, Seth D Fortmann, Moo Hyun Kim
The Journal of Invasive Cardiology|June 18, 2016
Alternative Rota-Flush Solution for Patients With Severe Coronary Artery Calcification who Undergo Rotational AtherectomyMichael S Lee, Moo-Hyun Kim, Seung-Woon Rha
Acta Cardiologica|September 9, 2017
Rosuvastatin inhibits high glucose-stimulated upregulation of VCAM-1 via the MAPK-signalling pathway in endothelial cellsMoo Hyun Kim, Chae-Eun Kim, Sung-Whan Kim
Pageof 26